A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 22 Aug 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 Aug 2022 Planned End Date changed from 1 Apr 2026 to 1 Dec 2024.
28 Feb 2022 According to a Humacyte media release, Prof. Tomasz Jakimowicz, M.D., Ph.D., of the Medical University of Warsaw, Poland, is a principal investigator of the trial.
28 Feb 2022 According to a Humacyte media release, five year long term results from the study, have been published in the European Journal of Vascular and Endovascular Surgery companion journal EJVES Vascular Forum.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com